Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Inpixon

Start price
Target price
Perf. (%)
€64.50
14.12.20
€150.00
6.98%
11.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
14.12.20 50%
buy
Avinger Inc.

Start price
Target price
Perf. (%)
€4.88
14.12.20
€20.00
301.64%
11.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
14.12.20 50%
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€14.22
14.12.20
€15.00
2.11%
15.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Traumtanz 
14.12.20 50%
buy
TOP Ships Inc.

Start price
Target price
Perf. (%)
€20.80
14.12.20
€40.00
28.85%
11.01.21

Could be very worthwhile Investment >20% year
DomRuinart 
14.12.20 50%
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.72
14.12.20
€2.00
14.12.21
9.69%
11.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
14.12.20 50%
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
DomRuinart 
14.12.20 50%
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€6.00
14.12.20
€8.00
14.12.21
6.67%
11.01.21

Could be very worthwhile Investment >20% year
DomRuinart 
14.12.20 50%
buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.20
14.12.20
€11.00
14.12.21
15.85%
29.01.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
me8 
14.12.20 50%
buy
Biocardia Inc.

Start price
Target price
Perf. (%)
€4.53
14.12.20
€5.00
14.12.21
-24.50%
29.01.21

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
me8 
14.12.20 50%
sell
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.90
14.12.20
€2.00
14.12.21
158.23%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
nvestor 
14.12.20 50%
sell
CBAK Energy Technology Inc

Start price
Target price
Perf. (%)
€4.06
14.12.20
€4.00
3.94%
16.12.20

Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Traumtanz 
14.12.20 50%
buy
Gazprom ADR

Start price
Target price
Perf. (%)
€4.58
14.12.20
-
14.12.21
67.50%
15.12.21

Good rating
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
shadow 
14.12.20 50%
buy
Anpac Bio-Medical Science Co.

Start price
Target price
Perf. (%)
€106.00
14.12.20
€240.00
14.12.21
-15.09%
29.01.21

Could be worthwhile Investment >10% per year
Good culture
Growths slower than the competition
Dependend from some customers or products
me8 
14.12.20 50%
buy
Synlogic Inc.

Start price
Target price
Perf. (%)
€3.00
14.12.20
€3.00
14.12.21
0.00%
29.01.21

Known brand
Could be worthwhile Investment >10% per year
Good culture
Business model of the past or high risk
me8 
14.12.20 50%
sell
Halliburton Co.

Start price
Target price
Perf. (%)
€16.52
14.12.20
-
14.12.21
21.50%
15.03.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
OldOrangeEyes 
14.12.20 50%
buy
Lenovo Group Ltd

Start price
Target price
Perf. (%)
€0.68
14.12.20
€1.00
4.41%
15.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Traumtanz 
14.12.20 50%
buy
Navya S.a.

Start price
Target price
Perf. (%)
€3.86
14.12.20
€5.00
14.12.21
-42.05%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
14.12.20 50%
buy
iBio Inc.

Start price
Target price
Perf. (%)
€25.75
14.12.20
€50.00
14.12.21
-45.17%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
14.12.20 50%
buy
U.S. Energy Corp.

Start price
Target price
Perf. (%)
€3.12
14.12.20
€4.00
14.12.21
-15.38%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
yester 
14.12.20 50%
buy
Aim Immunotech Inc.

Start price
Target price
Perf. (%)
€1.51
14.12.20
€2.00
14.12.21
-35.89%
15.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
14.12.20 50%
buy
ASML Holding N.V. ADR

Start price
Target price
Perf. (%)
€378.00
14.12.20
€510.00
22.22%
18.03.21

Capable Management
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Small cyclical dependencies
gerihouse 
14.12.20 80%
buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€499.50
14.12.20
€650.00
14.12.21
21.32%
13.05.21

Could be worthwhile Investment >10% per year
High dividend yield expected
Differentiated customer and product portfolio
Well known brand
gerihouse 
14.12.20 90%
buy
Zumtobel AG

Start price
Target price
Perf. (%)
€6.10
14.12.20
€7.00
6.39%
17.03.21

Known brand
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
gerihouse 
14.12.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€133.52
14.12.20
€170.00
14.12.21
7.26%
22.04.21

Capable Management
Medium risks for its business
Small cyclical dependencies
Could be very worthwhile Investment >20% year
gerihouse 
14.12.20 70%
sell
Evolus Inc

Start price
Target price
Perf. (%)
€3.13
14.12.20
-
-10.64%
28.12.20

Risky Investment
blaugold 
14.12.20 50%